144 related articles for article (PubMed ID: 21529065)
41. Activation of Langerhans cells promotes the inflammation in imiquimod-induced psoriasis-like dermatitis.
Xiao C; Zhu Z; Sun S; Gao J; Fu M; Liu Y; Wang G; Yao X; Li W
J Dermatol Sci; 2017 Mar; 85(3):170-177. PubMed ID: 27964879
[TBL] [Abstract][Full Text] [Related]
42. Neutrophil-dominant psoriasis-like skin inflammation induced by epidermal-specific expression of Raf in mice.
Tarutani M; Imai Y; Yasuda K; Tsutsui H; Nakanishi K; Yamanishi K
J Dermatol Sci; 2010 Apr; 58(1):28-35. PubMed ID: 20188517
[TBL] [Abstract][Full Text] [Related]
43. High salt diet impairs dermal tissue remodeling in a mouse model of IMQ induced dermatitis.
Pajtók C; Veres-Székely A; Agócs R; Szebeni B; Dobosy P; Németh I; Veréb Z; Kemény L; Szabó AJ; Vannay Á; Tulassay T; Pap D
PLoS One; 2021; 16(11):e0258502. PubMed ID: 34723976
[TBL] [Abstract][Full Text] [Related]
44. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation.
Nadeem A; Al-Harbi NO; Al-Harbi MM; El-Sherbeeny AM; Ahmad SF; Siddiqui N; Ansari MA; Zoheir KM; Attia SM; Al-Hosaini KA; Al-Sharary SD
Pharmacol Res; 2015 Sep; 99():248-57. PubMed ID: 26149470
[TBL] [Abstract][Full Text] [Related]
45. Application of OCT-Derived Attenuation Coefficient in Acute Burn-Damaged Skin.
Lu J; Deegan AJ; Cheng Y; Liu T; Zheng Y; Mandell SP; Wang RK
Lasers Surg Med; 2021 Nov; 53(9):1192-1200. PubMed ID: 33998012
[TBL] [Abstract][Full Text] [Related]
46. Resident and monocyte-derived Langerhans cells are required for imiquimod-induced psoriasis-like dermatitis model.
Lee M; Kim SH; Kim TG; Park J; Lee JW; Lee MG
J Dermatol Sci; 2018 Jul; 91(1):52-59. PubMed ID: 29655588
[TBL] [Abstract][Full Text] [Related]
47. Objective assessment of dermal fibrosis in cutaneous scarring, using optical coherence tomography, high-frequency ultrasound and immunohistomorphometry of human skin.
Ud-Din S; Foden P; Stocking K; Mazhari M; Al-Habba S; Baguneid M; McGeorge D; Bayat A
Br J Dermatol; 2019 Oct; 181(4):722-732. PubMed ID: 30729516
[TBL] [Abstract][Full Text] [Related]
48. RIPK1 downregulation in keratinocyte enhances TRAIL signaling in psoriasis.
Saito N; Honma M; Shibuya T; Iinuma S; Igawa S; Kishibe M; Ishida-Yamamoto A
J Dermatol Sci; 2018 Jul; 91(1):79-86. PubMed ID: 29661487
[TBL] [Abstract][Full Text] [Related]
49. Comparison of the histological changes in the skin of DBA/2 and C57BL/6 mice following exposure to various promoting agents.
Naito M; Naito Y; DiGiovanni J
Carcinogenesis; 1987 Dec; 8(12):1807-15. PubMed ID: 3119244
[TBL] [Abstract][Full Text] [Related]
50. TPA induction leads to a Th17-like response in transgenic K14/VEGF mice: a novel in vivo screening model of psoriasis.
Hvid H; Teige I; Kvist PH; Svensson L; Kemp K
Int Immunol; 2008 Aug; 20(8):1097-106. PubMed ID: 18579711
[TBL] [Abstract][Full Text] [Related]
51. The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression.
Palomo J; Troccaz S; Talabot-Ayer D; Rodriguez E; Palmer G
PLoS One; 2018; 13(3):e0194667. PubMed ID: 29554104
[TBL] [Abstract][Full Text] [Related]
52.
Fujii K; Yamamoto Y; Mizutani Y; Saito K; Seishima M
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752186
[No Abstract] [Full Text] [Related]
53. Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice.
Choi MR; Kim HD; Cho S; Jeon SH; Kim DH; Wee J; Yang YD
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281197
[TBL] [Abstract][Full Text] [Related]
54. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages.
Morimura S; Oka T; Sugaya M; Sato S
J Dermatol Sci; 2016 Jun; 82(3):175-88. PubMed ID: 26976687
[TBL] [Abstract][Full Text] [Related]
55. Local production of prolactin in lesions may play a pathogenic role in psoriatic patients and imiquimod-induced psoriasis-like mouse model.
Yang H; Li X; Xue F; Xia Q; Zhao X; Wang D; Chen L; Cao H; Xu H; Shen X; Yuan W; Zhao X; Shi R; Zheng J
Exp Dermatol; 2018 Nov; 27(11):1245-1253. PubMed ID: 30120801
[TBL] [Abstract][Full Text] [Related]
56. The Therapeutic Potential and Molecular Mechanism of Isoflavone Extract against Psoriasis.
Li HJ; Wu NL; Lee GA; Hung CF
Sci Rep; 2018 Apr; 8(1):6335. PubMed ID: 29679037
[TBL] [Abstract][Full Text] [Related]
57. Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides.
Li HJ; Wu NL; Pu CM; Hsiao CY; Chang DC; Hung CF
Sci Rep; 2020 Feb; 10(1):2932. PubMed ID: 32076123
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry; a double-blind, placebo-controlled trial.
Cossmann M; Welzel J
Br J Dermatol; 2006 Oct; 155(4):700-6. PubMed ID: 16965418
[TBL] [Abstract][Full Text] [Related]
59. 310 nm UV-LEDs attenuate imiquimod-induced psoriasis-like skin lesions in C57BL/6 mice and inhibit IL-22-induced STAT3 expression in HaCaT cells.
Kwon TR; Lee SE; Kim JH; Na Jang Y; Kim SY; Mun SK; Kim CW; Na J; Kim BJ
Photochem Photobiol Sci; 2020 Aug; 19(8):1009-1021. PubMed ID: 32584352
[TBL] [Abstract][Full Text] [Related]
60. Protective effects of ambroxol in psoriasis like skin inflammation: Exploration of possible mechanisms.
Sunkari S; Thatikonda S; Pooladanda V; Challa VS; Godugu C
Int Immunopharmacol; 2019 Jun; 71():301-312. PubMed ID: 30933843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
